Your browser doesn't support javascript.
loading
Bosutinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukaemia: results from the 24-month follow-up of the BELA trial.
Brümmendorf, Tim H; Cortes, Jorge E; de Souza, Cármino Antonio; Guilhot, Francois; Duvillié, Ladan; Pavlov, Dmitri; Gogat, Karïn; Countouriotis, Athena M; Gambacorti-Passerini, Carlo.
Affiliation
  • Brümmendorf TH; Universitätsklinikum Aachen, RWTH Aachen, Aachen, Germany; Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany.
Br J Haematol ; 168(1): 69-81, 2015 Jan.
Article in En | MEDLINE | ID: mdl-25196702

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Piperazines / Pyrimidines / Quinolines / Benzamides / Leukemia, Myeloid, Chronic-Phase / Protein Kinase Inhibitors / Aniline Compounds / Antineoplastic Agents / Nitriles Type of study: Clinical_trials / Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Br J Haematol Year: 2015 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Piperazines / Pyrimidines / Quinolines / Benzamides / Leukemia, Myeloid, Chronic-Phase / Protein Kinase Inhibitors / Aniline Compounds / Antineoplastic Agents / Nitriles Type of study: Clinical_trials / Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Br J Haematol Year: 2015 Document type: Article Affiliation country: Country of publication: